The chain of events that occurs during a migraine attack is incredibly complex, and the phenomenon continues to perplex medical researchers even today! This is one reason why figuring out how to effectively treat migraine pain is so challenging. A migraine procedure can block pain before it takes hold, and this treatment is best intended for those suffering with a chronic condition. For people with episodic migraines and headaches, pain drugs are helpful but side effects and rebound headaches could be unpleasant consequences.
A recent body of research and migraine treatment development has focused on preventing the pain-promoting hormone, calcitonin gene-related peptide (CGRP) from completing its dastardly work during a migraine attack. The drugs developed until now that work to block the CRGP receptors in the head, known as ‘gepants,’ don’t always work very well according to researchers from the University of Auckland in New Zealand.
This is why the scientist in New Zealand sought to determine what else might be happening during a migraine. According to the University’s website, they discovered that a second nerve receptor was implicated. One of the lead researchers said, “We have discovered that CGRP activates a second target on the surface of pain-sensing nerve cells, called AMY1, which the gepants are not designed to block.” He added, “This may be the key to treating migraine and opens the door for the design of new drugs that block this second target.”
It’s exciting to think that research is moving toward ever more targeted approaches for treating migraine pain. Fortunately, for people with a chronic headache or migraine condition, there is no need to wait until the scientists discover a better mousetrap. The Omega migraine procedure captures the essence of all of this ongoing research, by simply blocking the transmission of pain signals to the nerves involved with migraines. Without depending on drugs, the patient can control how much and when the implanted neurotransmitter needs to step up and play defense to ‘protect’ the nerve receptors in the head. It’s certainly good news, to know that migraineurs have more options now for treating their symptoms than ever before.